Industrial biotechnology uses living organisms or their molecular machinery to manufacture chemicals, materials, fuels, and other products that have traditionally come from petroleum or conventional chemistry. Sometimes called “white biotechnology” to distinguish it from medical (red) and agricultural (green) applications, the field essentially treats biology as a manufacturing platform.1PubMed. White biotechnology: State of the art strategies for the development of biocatalysts for biorefining The scope is broader than most people expect, reaching from laundry detergent enzymes to sustainable aviation fuel, and its environmental promise is real but not automatic.
The Two Biological Workhorses
At its core, industrial biotechnology relies on two kinds of biological tools: isolated enzymes and whole engineered microorganisms. Enzymes are proteins that catalyze specific chemical reactions, and industry uses them to make everything from pharmaceutical intermediates and flavor compounds to bulk chemicals.2PubMed Central. Biocatalysis: Enzymatic Synthesis for Industrial Applications Because enzymes work under mild conditions and produce fewer unwanted byproducts than traditional chemical catalysts, they tend to generate less waste and consume less energy for the same transformation.
Protein engineering has pushed enzymes well beyond what nature originally designed them to do. Researchers can now optimize existing enzymes or create entirely new reactions that were previously unknown in biology. Immobilizing an enzyme on a solid support can also improve its stability and allow it to be reused many times, which makes the economics much more favorable for large-scale production.3PubMed. Role of Biocatalysis in Sustainable Chemistry
The second workhorse is the microbial cell factory: a microorganism (often a bacterium or yeast) that has been genetically reprogrammed to convert simple carbon sources into a desired chemical. Think of it as a tiny chemical plant running on sugar instead of crude oil. Over the past two decades, researchers have engineered microorganisms capable of producing both natural and non-natural chemicals from renewable feedstocks.4PubMed Central. A comprehensive metabolic map for production of bio-based chemicals These cell factories are designed to channel as much of the cell’s metabolism as possible toward the target product, rather than toward growth or maintenance.5PubMed Central. Designing Microbial Cell Factories for the Production of Chemicals
What Industrial Biotechnology Actually Makes
The product range is surprisingly wide. One of the most familiar examples is bioethanol, fermented from sugars and used as a transportation fuel or a building block for other chemicals. But the list extends to organic acids like succinic acid and lactic acid, amino acids used in food and animal feed, specialty chemicals for cosmetics and flavoring, and even biodegradable plastics.
Polyhydroxyalkanoates, or PHAs, are a family of biodegradable polyesters made by bacteria. Many microorganisms naturally accumulate these polymers as internal energy reserves when nutrients are unbalanced, storing them in tiny granules inside the cell. Over 150 different monomer building blocks have been identified, though the most common industrial targets are based on just two of them.6PubMed. Bacterial production of the biodegradable plastics polyhydroxyalkanoates PHAs can behave like conventional plastics in packaging and disposable goods but break down in soil or marine environments, which makes them attractive as petroleum-plastic replacements.
On the more exotic end, researchers are producing recombinant spider silk proteins in bacteria, yeast, plants, and even mammalian cells.7PubMed Central. Recombinant Spider Silk: Promises and Bottlenecks Natural spider silk is extraordinarily tough and lightweight, properties that make it interesting for medical sutures, textiles, and composite materials. Farming spiders is impractical because they are territorial and cannibalistic, so industrial biotechnology steps in as the only realistic route to large-scale supply. Teams have produced synthetic spider silk proteins in E. coli that yield biomaterials comparable to those spun by orb-weaving spiders.8Protein Expression and Purification. Large scale production of synthetic spider silk proteins in Escherichia coli
Products You Already Use
You probably interact with industrial biotechnology every time you do laundry. Enzymes in detergent formulations break down specific types of stains: lipases target greasy food residues, amylases work on starchy smears, and proteases handle protein-based stains like blood or grass. Research has shown that certain plant-derived lipase and mannanase enzymes can effectively remove chocolate and mustard-oil stains at both low and high wash temperatures, and in some cases outperform commercial microbial enzymes above 70 °C.9PubMed Central. Validation of leaf enzymes in the detergent and textile industries: launching of a new platform technology The textile industry also uses enzymes to fade denim (the “stone-washed” look) and to smooth knitted fabrics by removing surface fuzz, replacing harsh chemical treatments that would otherwise generate polluted wastewater.
What Goes In: Feedstocks and the Shift Away From Food Crops
First-generation bioprocesses relied on food crops like corn and sugarcane as their primary sugar source, which raised legitimate concerns about competition with the food supply. The field has been steadily moving toward lignocellulosic biomass: agricultural residues such as corn stover and wheat straw, forestry waste, and dedicated energy crops that do not compete with food production.10Current Research in Biotechnology. Lignocellulosic bioethanol production: a review on pretreatment strategies, biofuel separation, and artificial intelligence/machine learning − based sustainable optimization
The challenge with lignocellulosic material is that the sugars are locked inside tough cell-wall structures. Breaking them free requires pretreatment (physical, chemical, or thermal) followed by enzymatic hydrolysis, where specialized cellulolytic enzymes chop cellulose and hemicellulose into fermentable sugars. Multiple enzyme strategies have been developed for different biomass types, including wood, agricultural waste, and even marine algae.11PubMed Central. Bioethanol Production by Enzymatic Hydrolysis from Different Lignocellulosic Sources This additional processing adds cost and complexity, which is one reason second-generation biofuels have been slower to reach commercial scale than early advocates predicted.
A separate approach skips biomass sugars entirely and feeds microorganisms on waste gases. Syngas fermentation uses bacteria that can consume carbon monoxide and hydrogen, gases that can come from gasified municipal waste or industrial off-gases. It is still at an earlier stage of commercialization, but several pilot plants are operating.
Sustainable Aviation Fuel as a Test Case
Aviation is one of the hardest transportation sectors to decarbonize because batteries are too heavy for long-haul flight. Sustainable aviation fuel, or SAF, made through biotechnology routes is one of the few realistic near-term options. Two pathways with high technological readiness are hydrotreating of esters and fatty acids (HEFA), which converts plant oils or waste fats into jet fuel, and Alcohol-to-Jet (ATJ), which chemically upgrades bioethanol into kerosene-range hydrocarbons.12Sustainability. Is Sustainable Aviation Fuel Production Through Hydroprocessing of Esters and Fatty Acids (HEFA) and Alcohol-to-Jet (ATJ) Technologies Feasible in Mexico?
Economic feasibility depends heavily on feedstock cost. A techno-economic analysis of ATJ production in Brazil estimated breakeven prices of roughly $1.86 to $2.57 per kilogram of biojet fuel, and the price of ethanol turned out to be the single most important factor in the cost structure.13Energy Conversion and Management. Process simulation and economic evaluation of the Alcohol-to-Jet production of sustainable aviation fuel in the Brazilian context That finding is a good illustration of a recurring pattern in industrial biotech: the biology often works, but the economics hinge on feedstock prices and the cost of competing fossil products.
Getting From Lab Bench to Factory Floor
A fermentation that works in a benchtop flask does not automatically work in a 100,000-liter steel bioreactor. Scaling up is one of the field’s persistent headaches. Oxygen transfer is often the rate-limiting step in aerobic fermentation because oxygen dissolves poorly in liquid. Predicting and controlling the rate at which oxygen moves from gas bubbles into the broth is essential for bioreactor design, and it depends on everything from agitation speed to the physical properties of the culture medium.14PubMed. Bioreactor scale-up and oxygen transfer rate in microbial processes: an overview
Shear stress is another concern, particularly with filamentous fungi and other organisms whose shape and productivity change depending on how vigorously the liquid is stirred. Novel bioreactor designs, such as coaxial mixers that combine an inner and outer impeller, have shown promise for achieving good oxygen transfer while keeping shear forces low enough to avoid damaging sensitive organisms.15PubMed. Analyzing of hydrodynamic stress and mass transfer requirements of a fermentation process carried out in a coaxial bioreactor: a scale-up study
After the bioreactor, you still have to get your product out of a complex soup of cells, proteins, salts, and leftover nutrients. This downstream processing, the separation and purification stage, remains a major cost driver. Despite advances, challenges like product loss at each purification step and overall process complexity continue to limit profitability for many bioprocesses.
The Environmental Scorecard
One of the strongest arguments for industrial biotechnology is the potential to lower greenhouse gas emissions. A large-scale analysis comparing emerging bio-based products to their fossil-based counterparts found that, on average, the bio-based versions had greenhouse gas footprints about 45% lower. The majority of products studied showed reductions, and some, like wood-fiber biocomposites, achieved cuts of more than 90%.16Nature Communications. The potential of emerging bio-based products to reduce environmental impacts
But “on average” hides enormous variation. The same analysis found that lignin-based bioadhesives actually had a greenhouse gas footprint roughly three times higher than their fossil counterpart, and no bio-based product in the study reached net-zero emissions.16Nature Communications. The potential of emerging bio-based products to reduce environmental impacts The lesson is that “bio-based” does not automatically mean “green.” Land use change, energy-intensive pretreatment, and fertilizer for biomass crops can all erode or even reverse the carbon benefits. Each product needs to be evaluated on its own life-cycle merits rather than riding on the assumption that biology is inherently cleaner.
Waste as a Resource
Industrial biotechnology aligns well with the concept of a circular bioeconomy, where waste streams become feedstocks. Organic wastes, whether agricultural residues, food processing byproducts, or municipal wastewater, contain carbon and energy that can be captured by microorganisms and turned into useful chemicals. This reframing of waste as a resource is gaining traction, with biorefinery approaches that integrate waste treatment with the production of biopolymers, bio-lipids, and other metabolites.17PubMed Central. Waste biorefinery towards a sustainable circular bioeconomy: a solution to global issues
Even gaseous waste streams are fair game. Microbial electrosynthesis and electro-fermentation techniques can convert waste COâ‚‚ and organic waste into value-added chemicals and materials, treating carbon-rich residues not as a disposal problem but as a feedstock for new production cycles.18PubMed. Carbon dioxide and organic waste valorization by microbial electrosynthesis and electro-fermentation
How Machine Learning Is Changing Enzyme Design
Protein engineering used to be painstaking: mutate a gene, grow a colony, test the enzyme, repeat. Directed evolution, the approach that won Frances Arnold the 2018 Nobel Prize in Chemistry, sped things up considerably but still relied on screening large numbers of random variants. Now machine learning is compressing that process further.
A method called Active Learning-assisted Directed Evolution, or ALDE, uses uncertainty-quantifying algorithms to decide which enzyme variants are most worth testing in the next round of experiments. In one demonstration, researchers improved the yield of a non-native reaction from about 12% to 93% in just three rounds of lab work.19Nature Communications. Active learning-assisted directed evolution Another framework, MULTI-evolve, combines protein language models with epistatic modeling to predict which combinations of mutations will work together synergistically. Applied to three different proteins, it achieved up to tenfold improvements in a single round of guided evolution.20PubMed Central. Rapid directed evolution guided by protein language models and epistatic interactions
These tools matter for industrial biotechnology because enzyme performance is often the bottleneck. A reaction that is chemically possible but too slow, too unstable, or too unselective for factory conditions can become viable once the enzyme is tuned. Faster, smarter enzyme optimization translates directly into shorter development timelines and cheaper processes.
Cell-Free Manufacturing
An emerging alternative to whole-cell fermentation dispenses with living organisms altogether. Cell-free systems use the biological machinery, primarily enzymes and cofactors, harvested from cells but operating outside them. Because these platforms do not have to keep an organism alive, they are not constrained by cellular survival needs that often work against production goals. They can also tolerate molecules that would be toxic to living cells.21PubMed. Toward sustainable, cell-free biomanufacturing
Cell-free metabolic engineering offers several practical advantages: faster design-build-test cycles because you do not have to re-engineer an organism each time, higher volumetric production rates in some cases, and the ability to carry out transformations where yields or toxicity would be showstoppers in a living cell.22PubMed Central. Cell-free metabolic engineering: biomanufacturing beyond the cell The approach is highly adaptable to different production and testing schemes, which makes it useful not just for manufacturing but also for rapid prototyping of new biosynthetic pathways.23PubMed Central. Biotechnology Applications of Cell-Free Expression Systems Cell-free systems are still more expensive per unit of product than fermentation for many applications, but for high-value or difficult-to-make compounds, the trade-off can be worthwhile.
The Economics of Competing With Petroleum
The fundamental economic tension in industrial biotechnology is that it must compete with petrochemical processes that have benefited from a century of optimization and enormous scale. A techno-economic analysis of 15 bio-based bulk chemicals found that for certain products, particularly ethanol, 1,3-propanediol, and succinic acid, biotechnological routes were already economically viable even at an oil price of $25 per barrel. Others, like bio-based ethylene and polylactic acid, needed oil prices closer to $50 per barrel to break even. Projected future improvements in bioprocess technology were estimated to cut production costs by 20 to 50% across the board.24PubMed. Today’s and tomorrow’s bio-based bulk chemicals from white biotechnology: a techno-economic analysis
Those numbers illustrate a key point: the economic competitiveness of bio-based products is not fixed. It shifts with oil prices, sugar prices, carbon taxes, and the pace of bioprocess improvement. Policy instruments like carbon pricing or blending mandates (as in the case of SAF) can tip the balance, but they also introduce uncertainty that makes long-term investment risky. Companies entering the space need to be realistic about which products can stand on their own economics today and which ones depend on favorable policy or higher fossil fuel prices to survive.
Regulation and Public Perception
Because many industrial biotechnology processes involve genetically modified organisms, they inevitably run into regulatory frameworks designed for different eras of biology. In Europe, the regulatory distinction between “contained use” (organisms kept inside a facility) and “deliberate release” (organisms deployed in the environment) drives much of the approval process. Some newer applications fall awkwardly between these two categories. For example, an arsenic biosensor built using engineered Bacillus subtilis, a well-characterized nonpathogenic bacterium with generally-regarded-as-safe status, was designed with multiple layers of containment: disabling mutations that made the organism less fit than its parent, nutrient dependencies that prevented it from surviving outside the device, and physical enclosure behind welded polycarbonate.25Synthetic Biology. Synthetic biology regulation in Europe: containment, release and beyond Even with all these safeguards, navigating the regulatory pathway was not straightforward, because the device was intended for field use but the organism was not meant to be released. These edge cases are becoming more common as industrial biotech products move outside factory walls.
Public acceptance is a separate challenge. Consumer attitudes toward genetic modification are shaped less by factual knowledge than by perceived knowledge. Research on willingness to pay for non-GMO labels found that people who believed they knew a lot about GMOs but actually scored low on objective knowledge tests were willing to pay the highest premiums for non-GMO labeling, more than people with genuinely high knowledge on the subject.26PLoS ONE. Perceived subjective versus objective knowledge: Consumer valuation of genetically modified certification on food producing plants That finding suggests that education campaigns aimed at increasing factual understanding could be more effective at shaping attitudes than marketing that simply reinforces existing anxieties. For industrial biotechnology, though, most products (bulk chemicals, biofuels, enzymes in detergent) are several steps removed from the consumer’s plate, which means the “GMO” framing carries less emotional weight than it does for food crops. The perception challenge for the industry is less about fear and more about invisibility: most people simply have no idea how many products in their daily lives already depend on engineered biology.